GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Intervacc AB (OSTO:IVACC) » Definitions » Ending Cash Position

Intervacc AB (OSTO:IVACC) Ending Cash Position : kr71.88 Mil (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Intervacc AB Ending Cash Position?

Intervacc AB's Ending Cash Position for the quarter that ended in Mar. 2024 was kr71.88 Mil.

Intervacc AB's quarterly Ending Cash Position declined from Sep. 2023 (kr98.65 Mil) to Dec. 2023 (kr88.34 Mil) and declined from Dec. 2023 (kr88.34 Mil) to Mar. 2024 (kr71.88 Mil).

Intervacc AB's annual Ending Cash Position declined from Dec. 2021 (kr115.71 Mil) to Dec. 2022 (kr45.70 Mil) but then increased from Dec. 2022 (kr45.70 Mil) to Dec. 2023 (kr88.34 Mil).


Intervacc AB Ending Cash Position Historical Data

The historical data trend for Intervacc AB's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intervacc AB Ending Cash Position Chart

Intervacc AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 52.54 164.25 115.71 45.70 88.34

Intervacc AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34.95 113.27 98.65 88.34 71.88

Intervacc AB Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Intervacc AB's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=45.699+42.642
=88.34

Intervacc AB's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=88.341+-16.464
=71.88


Intervacc AB Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Intervacc AB's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Intervacc AB (OSTO:IVACC) Business Description

Traded in Other Exchanges
Address
Vastertorpsvagen 135, Hagersten, Stockholm, SWE, S-129 44
Intervacc AB is a biotechnology company. It develops new vaccines based on recombinant proteins to meet the increasing need for effective vaccines in animal health care. The company through its subsidiary focuses on diagnostics in the Swedish animal health market and offers bacteriological and mycological analyses on the Swedish market.

Intervacc AB (OSTO:IVACC) Headlines

No Headlines